X
Record #43649

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer

Original paper date
Jan 30, 2022
Institution
Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China · Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE, USA · School of Medicine, University of Electronic Science and Technology of China, Chengdu, China · Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China · Southwest Medical University, Luzhou City, Sichuan Province, China · Boao Evergrande International Hospital, Qionghai, Hainan Province, China · Cancer Center, Sichuan Friendship Hospital, Chengdu, Sichuan Province, China · Cancer Center, Ziyang People's Hospital, Ziyang, Sichuan Province, China · Dazhou Central Hospital, Dazhou, Sichuan Province, China · Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan Province, China · Cancer Center, First Affiliated Hospital of Hainan Medical College, National Drug Clinical Trial Institute, Haikou, Hainan Province, China · Cancer Center, West China Hospital, Chengdu, Sichuan Province, China
Open access
No
Article type
Research Article
Broad categories
(BLS) Biology - Cancer(BLS) Biology - Cellular(BLS) Biology - Molecular
Citation lifecycle

How this paper is being cited

Pre-retraction
6
Same day
0
Post-retraction
220
% post-retraction
97.3%
~35.9 citations/yr before retraction · ~49.3 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse